Company Overview - Inari Medical, now part of Stryker, has launched the next-generation InThrill Thrombectomy System, which is the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system designed for fast, full luminal clot removal [1][2][3]. Product Features - The InThrill Thrombectomy System is an 8 French over-the-wire system that includes the InThrill thrombectomy catheter and sheath, optimized to set a new standard for AV access and small vessel thrombectomy [3]. - Key features of the InThrill system include increased radial force for improved luminal wall apposition, an offset single open mouth for optimized clot capture, internal struts for even clot distribution, and a redesigned backend for enhanced ergonomics [9]. Clinical Application - The system is indicated for the non-surgical removal of thrombi and emboli from blood vessels, including arteriovenous fistulae and grafts for dialysis access, as well as for the injection, infusion, and aspiration of contrast media and other fluids [7]. Market Impact - The launch of the InThrill Thrombectomy System reflects Stryker's commitment to addressing real-world challenges in vascular care, enhancing collaboration with physicians in the vascular space [4]. - Stryker, as a global leader in medical technologies, impacts over 150 million patients annually through innovative products and services [4]. Acquisition Context - Stryker acquired Inari Medical on February 19, 2025, with the aim of transforming the treatment of patients suffering from venous and other diseases [5].